Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Effect of transdermal testosterone replacement in hypogonadal men with decreased insulin sensitivity

Trial Profile

Effect of transdermal testosterone replacement in hypogonadal men with decreased insulin sensitivity

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Apr 2015

At a glance

  • Drugs Testosterone (Primary)
  • Indications Hypogonadism; Insulin resistance; Metabolic syndrome; Type 2 diabetes mellitus
  • Focus Adverse reactions; Pharmacodynamics; Pharmacogenomic
  • Acronyms TIMES-2
  • Most Recent Events

    • 06 Jan 2012 Actual end date changed from Jun 2008 to Aug 2008 as reported by ISRCTN: Current Controlled Trials
    • 30 Mar 2011 Results have been published in Diabetes Care, according to a ProStrakan media release.
    • 18 Jun 2008 Testosterone gel is expected to be filed for approval in the US in the second half of 2008, according to a ProStrakan media release..
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top